Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

SC collegium decides to drop Dinakaran recommendation
The Supreme Court collegium has decided to drop its recommendation for elevating Karnataka Chief Justice P D Dinakaran, facing charges of land grabbing, to the apex court, bringing to end months of controversy over the move.

Australia to provide India details of attacks on Indians
Amid a spate of attacks on Indians here, the Victorian government today said it will provide all relevant details to New Delhi on these incidents.

News of the day

Stick to the point
Finance Minister Pranab Mukherjee is known to stick to the subject at hand and not get into long discussions. So, when CPI leader Gurudas Dasgupta raised a calling attention motion on the merger of banks and started making several ideological points, this made Mukherjee testy.
Business Ideas

Ranbaxy gets Canada's nod to mkt anti-hypertension drug

Pharma company Ranbaxy Laboratories today said it has received the final approval of the Canadian drug regulator Therapeutic Products Directorate (TPD) to market and manufacture "Ran-Amlodipine tablets", used in treating hypertensions. - Teva Pharma recalls anti-anxiety drug Propofol - Zenotech wants independent valuation for Daiichi open offer">Zenotech wants independent valuation for Daiichi open offer - Madras HC halts Daiichi"s open offer for Zenotech - Medicine for all - Shasun to invest Rs 100 cr for setting up new Vizag plant - Ranbaxy recalls drug from US mkt The company has got the approval for Ran-Amlodipine (Amlodipine Besylate tablets) in 5 and 10 mg strengths, through its wholly-owned subsidiary Ranbaxy Pharmaceuticals- Canada Inc (RPCI), Gurgaon-based (RPCI) said in a statement. "We look forward to marketing both strengths of Ran-Amlodipine tablets at affordable prices that will be beneficial to both the Canadian healthcare system, and most importantly to Canadian patients," RPCI President Paul Drake said. The total market for Amlodipine Besylate tablets in Canada is 456 million Canadian dollars.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009